Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» J&J’s Prostate Drug Extends Life as Spur to $5 Billion Market
J&J’s Prostate Drug Extends Life as Spur to $5 Billion Market
J&J’s Prostate Drug Extends Life as Spur to $5 Billion Market
Submitted by
admin
on June 2, 2011 - 10:25am
Source:
Bloomberg
News Tags:
prostate cancer
JNJ
Zytiga
Headline:
J&J’s Prostate Drug Extends Life as Spur to $5 Billion Market
Do Not Allow Advertisers to Use My Personal information
